116 related articles for article (PubMed ID: 20137900)
1. Activity of tigecycline against methicillin-resistant Staphylococcus aureus (MRSA) from respiratory tract sources.
Hawser SP
Int J Antimicrob Agents; 2010 Apr; 35(4):414-5. PubMed ID: 20137900
[No Abstract] [Full Text] [Related]
2. In vitro activity of tigecycline in combination with gentamicin against biofilm-forming Staphylococcus aureus.
McConeghy KW; LaPlante KL
Diagn Microbiol Infect Dis; 2010 Sep; 68(1):1-6. PubMed ID: 20727462
[TBL] [Abstract][Full Text] [Related]
3. In vitro activity of tigecycline against extended-spectrum β-lactamase-producing Enterobacteriaceae and MRSA clinical isolates from Mexico: a multicentric study.
Silva-Sanchez J; Reyna-Flores F; Velazquez-Meza ME; Rojas-Moreno T; Benitez-Diaz A; Sanchez-Perez A;
Diagn Microbiol Infect Dis; 2011 Jun; 70(2):270-3. PubMed ID: 21596226
[TBL] [Abstract][Full Text] [Related]
4. Minocycline versus doxycycline for meticillin-resistant Staphylococcus aureus (MRSA): in vitro susceptibility versus in vivo effectiveness.
Cunha BA
Int J Antimicrob Agents; 2010 May; 35(5):517-8. PubMed ID: 20202796
[No Abstract] [Full Text] [Related]
5. Impact of biofilm on the in vitro activity of vancomycin alone and in combination with tigecycline and rifampicin against Staphylococcus aureus.
Rose WE; Poppens PT
J Antimicrob Chemother; 2009 Mar; 63(3):485-8. PubMed ID: 19109338
[TBL] [Abstract][Full Text] [Related]
6. In vitro activity of minocycline combined with fosfomycin against clinical isolates of methicillin-resistant Staphylococcus aureus.
Sun C; Falagas ME; Wang R; Karageorgopoulos DE; Yu X; Liu Y; Cai Y; Liang B; Song X; Liu Z
J Antibiot (Tokyo); 2011 Aug; 64(8):559-62. PubMed ID: 21772306
[TBL] [Abstract][Full Text] [Related]
7. Doxycycline, not minocycline, induces its own resistance in multidrug-resistant, community-associated methicillin-resistant Staphylococcus aureus clone USA300.
Schwartz BS; Graber CJ; Diep BA; Basuino L; Perdreau-Remington F; Chambers HF
Clin Infect Dis; 2009 May; 48(10):1483-4. PubMed ID: 19374563
[No Abstract] [Full Text] [Related]
8. Evaluation of dalbavancin, tigecycline, minocycline, tetracycline, teicoplanin and vancomycin against community-associated and multidrug-resistant hospital-associated meticillin-resistant Staphylococcus aureus.
Huang V; Cheung CM; Kaatz GW; Rybak MJ
Int J Antimicrob Agents; 2010 Jan; 35(1):25-9. PubMed ID: 19900792
[TBL] [Abstract][Full Text] [Related]
9. Tigecycline inhibition of a mature biofilm in clinical isolates of Staphylococcus aureus : comparison with other drugs.
Cafiso V; Bertuccio T; Spina D; Purrello S; Stefani S
FEMS Immunol Med Microbiol; 2010 Aug; 59(3):466-9. PubMed ID: 20528931
[TBL] [Abstract][Full Text] [Related]
10. Comparison of ceftaroline fosamil, daptomycin and tigecycline in an experimental rabbit endocarditis model caused by methicillin-susceptible, methicillin-resistant and glycopeptide-intermediate Staphylococcus aureus.
Jacqueline C; Amador G; Batard E; Le Mabecque V; Miègeville AF; Biek D; Caillon J; Potel G
J Antimicrob Chemother; 2011 Apr; 66(4):863-6. PubMed ID: 21393213
[TBL] [Abstract][Full Text] [Related]
11. In vitro activity of tigecycline against methicillin-resistant Staphylococcus aureus, including livestock-associated strains.
Verkade EJ; Verhulst CJ; Huijsdens XW; Kluytmans JA
Eur J Clin Microbiol Infect Dis; 2010 May; 29(5):503-7. PubMed ID: 20186450
[TBL] [Abstract][Full Text] [Related]
12. Methicillin-resistant Staphylococcus aureus: the superbug.
Ippolito G; Leone S; Lauria FN; Nicastri E; Wenzel RP
Int J Infect Dis; 2010 Oct; 14 Suppl 4():S7-11. PubMed ID: 20851011
[TBL] [Abstract][Full Text] [Related]
13. Antimicrobial activity of tigecycline against community-acquired methicillin-resistant Staphylococcus aureus isolates recovered from North American medical centers.
Mendes RE; Sader HS; Deshpande L; Jones RN
Diagn Microbiol Infect Dis; 2008 Apr; 60(4):433-6. PubMed ID: 18068326
[TBL] [Abstract][Full Text] [Related]
14. Comparative activity of telavancin and other antimicrobial agents against methicillin-resistant Staphylococcus aureus isolates collected from 1991 to 2006.
Shams W; Walker ES; Levy F; Reynolds SA; Peterson SM; Sarubbi FA
Chemotherapy; 2010; 56(5):411-6. PubMed ID: 20948212
[TBL] [Abstract][Full Text] [Related]
15. Oxacillin- and cefoxitin-susceptible meticillin-resistant Staphylococcus aureus (MRSA).
Cuirolo A; Canigia LF; Gardella N; Fernández S; Gutkind G; Rosato A; Mollerach M
Int J Antimicrob Agents; 2011 Feb; 37(2):178-9. PubMed ID: 21163627
[No Abstract] [Full Text] [Related]
16. In vitro susceptibility patterns of methicillin-resistant Staphylococcus aureus and coagulase-negative Staphylococcus corneal isolates to antibiotics.
Elsahn AF; Yildiz EH; Jungkind DL; Abdalla YF; Erdurmus M; Cremona FA; Rapuano CJ; Hammersmith KM; Cohen EJ
Cornea; 2010 Oct; 29(10):1131-5. PubMed ID: 20595899
[TBL] [Abstract][Full Text] [Related]
17. Vancomycin minimum inhibitory concentrations (MICs) for meticillin-resistant Staphylococcus aureus (MRSA) in Hong Kong.
Ip M; Chau SS; Lui SL; Leung E; Ling T
Int J Antimicrob Agents; 2010 Oct; 36(4):386-7. PubMed ID: 20702065
[No Abstract] [Full Text] [Related]
18. Minocycline--an old drug for a new century: emphasis on methicillin-resistant Staphylococcus aureus (MRSA) and Acinetobacter baumannii.
Bishburg E; Bishburg K
Int J Antimicrob Agents; 2009 Nov; 34(5):395-401. PubMed ID: 19665876
[TBL] [Abstract][Full Text] [Related]
19. Comparing antimicrobial susceptibility of meticillin-resistant Staphylococcus aureus (MRSA) to vancomycin using MicroScan (Pos Combo 3.1J) and conventional methods.
Nakashima H; Kameko M; Takahashi H; Saito H
Int J Antimicrob Agents; 2010 Sep; 36(3):291-3. PubMed ID: 20594808
[No Abstract] [Full Text] [Related]
20. Efficacy of tigecycline alone and with rifampin in foreign-body infection by methicillin-resistant Staphylococcus aureus.
Garrigós C; Murillo O; Euba G; Verdaguer R; Tubau F; Cabellos C; Cabo J; Ariza J
J Infect; 2011 Sep; 63(3):229-35. PubMed ID: 21763722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
